Belgium
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 17.15 B
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 6.15 B
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 4.81 B
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
4 |
USD 3.22 B
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
5 |
USD 659.52 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
The Biotechnology company in Belgium with the highest Total Assets is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 17.15 B.
The Biotechnology company in Belgium with the lowest Total Assets is Ion Beam Applications SA (Brussels Stock Exchange: IBAB.BR) at USD 659.52 M.
The top 10 Biotechnology companies in Belgium by Total Assets are UCB SA, Azelis Group NV, Galapagos NV, Tessenderlo Group NV and Ion Beam Applications SA.
The bottom 10 Biotechnology companies in Belgium by Total Assets are Ion Beam Applications SA, Tessenderlo Group NV, Galapagos NV, Azelis Group NV and UCB SA.